SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-20-001219
Filing Date
2020-10-01
Accepted
2020-10-01 16:27:41
Documents
2
Period of Report
2020-09-29

Document Format Files

Seq Description Document Type Size
1 e619973_4-larimar.html 4  
1 e619973_4-larimar.xml 4 7223
2 e619973_ex99.htm EX-99 3557
  Complete submission text file 0001193805-20-001219.txt   13033
Mailing Address 780 THIRD AVENUE, 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 201216282

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36510 | Film No.: 201216281

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations